Nina Ossanna
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$3.1MFederal grants as PI7 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
7 awards · $3.1M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 18, 2023 | NIH | SBIR Phase I GMP Manufacturing and IND Enabling Studies of Extended-Release PNA5: ANovel Therapeutic for Treating Cognitive Impairment in Patients at-risk for Alzheimer's Disease-Related Dementias and Vascular | $500K | Proneurogen, Inc |
| Sep 30, 2022 | NIH | SBIR Phase I Extended-Release Formulation of Mas Receptor Agonists as Novel Therapeutics for Treating Cognitive Impairment in Patients at-risk forAlzheimer's Disease-Related Dementias and Vascular Dementia | $500K | Proneurogen, Inc |
| Sep 1, 2022 | NIH | SBIR Phase I Scale-up Manufacturing and IND Enabling Studies of Extended-Release Formulation of Mas Receptor Agonist for Treating Vascular Cognitive Impairment and Alzheimer's Disease-Related Dementias | $500K | Proneurogen, Inc |
| Aug 15, 2020 | NIH | SBIR Phase I Formulation of a Novel Therapeutic for Treating Cognitive Impairment in Patients at-risk for Alzheimer's Disease-Related Dementias and Vascular Contributions to Cognitive Impairment | $439K | Proneurogen, Inc |
| Aug 5, 2020 | NIH | SBIR Phase I Formulation of a Novel Therapeutic for Treating Cognitive Impairment in Patients at-risk for Alzheimer's Disease-Related Dementias and Vascular Contributions to Cognitive Impairment | $439K | Proneurogen, Inc |
| Sep 17, 2019 | NIH | SBIR Phase I Novel formulations of Allopregnanolone to treat Alzheimer's Disease | $450K | Proneurogen, Inc |
| Jun 13, 2019 | NIH | SBIR Phase I Microneedle Formulation for Treating Cognitive Impairment in Patients at-risk for Alzheimer's Disease Related Dementia (ADRD) and Vascular Contributions to Cognitive Impairment and Dementia (VCID) | $223K | Proneurogen, Inc |
Peer ranks
Federal funding#587
Awards as PI#250
Patents#273
Companies
- Proneurogen, IncLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.